Advanced search

Search our library

Pneumonia
Best available therapy (BAT)
Streptococcus
Staphylococcus
Pseudomonas
Mycobacterium tuberculosis
Klebsiella
Efflux-mediated resistance
Gram-positive/negative
Fastidious bacteria
Prokaryotic cell
Carbapenem-resistant Enterobacteriaceae (CRE)
Enterobacteriaceae
Enterobacterales
Enterococcus
Eukaryotic cell
Urinary tract infection (UTI)
De-escalation
Acinetobacter
Aerobic bacteria
Anaerobic bacteria
Ventilator-associated pneumonia (VAP)
Skin and soft tissue infection (SSTI)
Intra-abdominal infection (IAI)
Bloodstream infection (BSI)
Abbreviated new drug application (ANDA)
Biologics license application (BLA)
Suspected unexpected serious adverse reaction (SUSAR)
Serious adverse event (SAE)
Quality assurance (clinical trials)
QT study
Power (clinical trials)
Prolongation of QT interval
Outcome, clinical trial
Orphan drug
Observational study
Investigational medicinal product (IMP)
Investigator’s brochure (IB), clinical
Number needed to treat (NNT)
No observed adverse effect level (NOAEL)
No observed effect level (NOEL)
Good Laboratory Practice (GLP)
Good Manufacturing Practice (GMP)
Informed consent
Institutional Review Board (IRB)
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
Double-blind
Eligibility criteria (inclusion/exclusion)
Endpoint, clinical trial
First-in-human
Good clinical practice
Dosing: BID, TID
Database lock (DBL)
Compassionate use, clinical
Clinical study report (CSR)
Clinical exposure-response (CER) relationship
Neisseria gonorrhoeae
Non-fermenter
APACHE II score
Clearance, renal